Queen of Hearts

Trends

• FDA authorizations extend clinical AI into new specialties and LLMs

Items

1. Sep 9

   FDA authorizes Queen of Hearts AI-ECG

   The first De Novo authorization for AI-ECG detection of STEMI and STEMI equivalents creates a new device class for acute cardiac diagnoses; registry data show 7.9% false-positive cath-lab activations with the tool versus 41.8% without.